- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Swiss Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Results
23
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
23 companies
Novartis
Market Cap: CHF 185.9b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 94.89
7D
-2.3%
1Y
1.0%
Roche Holding
Market Cap: CHF 208.0b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 259.30
7D
-3.9%
1Y
2.6%
Cosmo Pharmaceuticals
Market Cap: CHF 893.6m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 55.80
7D
-5.4%
1Y
-20.5%
Sandoz Group
Market Cap: CHF 18.8b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 43.63
7D
2.0%
1Y
33.1%
Galderma Group
Market Cap: CHF 26.6b
Operates as a dermatology company worldwide.
GALD
CHF 112.10
7D
0.7%
1Y
49.7%
Lonza Group
Market Cap: CHF 39.6b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 560.20
7D
-1.5%
1Y
17.4%
Santhera Pharmaceuticals Holding
Market Cap: CHF 151.9m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 11.80
7D
-3.3%
1Y
24.2%
Idorsia
Market Cap: CHF 387.2m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, and Canada.
IDIA
CHF 1.90
7D
-6.4%
1Y
-6.9%
Xlife Sciences
Market Cap: CHF 112.8m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 19.65
7D
0.8%
1Y
-36.0%
Tecan Group
Market Cap: CHF 2.0b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 160.40
7D
-3.3%
1Y
-48.0%
SKAN Group
Market Cap: CHF 1.6b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 72.50
7D
-2.0%
1Y
-8.6%
Curatis Holding
Market Cap: CHF 59.4m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 11.90
7D
0.4%
1Y
76.0%
Bachem Holding
Market Cap: CHF 4.4b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 58.30
7D
7.5%
1Y
-25.9%
Kuros Biosciences
Market Cap: CHF 979.2m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 25.52
7D
-1.5%
1Y
123.9%
Dottikon ES Holding
Market Cap: CHF 3.9b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries worldwide.
DESN
CHF 285.50
7D
-0.5%
1Y
10.4%
Addex Therapeutics
Market Cap: CHF 5.9m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.06
7D
-2.3%
1Y
-0.3%
Basilea Pharmaceutica
Market Cap: CHF 599.3m
Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.
BSLN
CHF 48.85
7D
-4.4%
1Y
20.5%
Molecular Partners
Market Cap: CHF 106.8m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 2.90
7D
-7.1%
1Y
-67.8%
BioVersys
Market Cap: CHF 205.0m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 35.20
7D
0.3%
1Y
n/a
Siegfried Holding
Market Cap: CHF 4.1b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 94.50
7D
0.3%
1Y
0.5%
PolyPeptide Group
Market Cap: CHF 655.3m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 19.86
7D
-2.6%
1Y
-35.6%
Newron Pharmaceuticals
Market Cap: CHF 141.9m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 7.11
7D
-1.9%
1Y
-33.7%
Relief Therapeutics Holding
Market Cap: CHF 28.0m
A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally.
RLF
CHF 2.23
7D
-2.0%
1Y
100.5%